Results 111 to 120 of about 3,023 (195)
Jutta Beier,1 Robert Mroz,2,3 Anne-Marie Kirsten,4 Ferran Chuecos,5 Esther Garcia Gil5 1insaf Respiratory Research Institute, Wiesbaden, Germany; 2Centrum Medycyny Oddechowej, 3Medical University of Białystok, Białystok, Poland; 4Pulmonary Research ...
Beier J +4 more
doaj
Currently, chronic obstructive pulmonary disease (COPD) is a 5-largest cause of death worldwide, and the reduced activities of daily living, productivity and disability explain a significant economic and social damage.
A. U. Kulikov, I. A. Komarov
doaj
Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
Roland Buhl,1 Donald Banerji21Pulmonary Department, Mainz University Hospital, Mainz, Germany; 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAAbstract: Bronchodilators are central in the symptomatic management of chronic obstructive ...
Buhl R, Banerji D
doaj
Chronic obstructive pulmonary disease is an inflammatory lung disease mainly caused by cigarette smoke inhalation. We aimed to evaluate the effect of tiotropium bromide, which is an anticholinergic bronchodilator, on inflammation and remodeling in the ...
OZKAN, Meyrem +5 more
core
Oral aphthous-like ulceration due to tiotropium bromide.
Unwanted side-effects of a drug therapy are well known to oral medicine specialists and other colleagues. Usually they manifest itself as dry mouth, taste disturbances, various allergic or toxic reactions on the lips and/or in the oral cavity. However, the list of the drugs which might induce unwanted reactions is everyday becoming longer as more and ...
Vucicevic-Boras, V. +2 more
openaire +7 more sources
Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol. [PDF]
Moretz C +8 more
europepmc +1 more source
Effect of different doses of Budesonide combined with Tiotropium bromide inhalation on elderly patients with chronic obstructive pulmonary disease. [PDF]
Yu J, Ni J, Chen X, Fang Y, Fu S.
europepmc +1 more source
Prevention and relief of symptoms by regular use of bronchodilators is central to the management of patients with chronic obstructive pulmonary disease (COPD). The bronchodilators in use are beta(2)-agonists, anticholinergics and theophylline.
Brusselle, Guy +3 more
core

